• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number JHJR071502J
Device Problem Complete Blockage (1094)
Patient Problems Aneurysm (1708); Occlusion (1984)
Event Date 08/19/2019
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records indicated the device met pre-release specifications.The device was not returned.Consequently, a direct product analysis was not possible.Additional information about this event could not be obtained.As a result, no further investigation is possible.All information has been placed on file for use in tracking and trending.
 
Event Description
The following was reported to gore; on (b)(6) 2019, the patient underwent endovascular repair.The gore® viabahn® endoprosthesis was implanted in the celiac artery as a chimney device.The procedure was completed without any complications.The same day (6 hours later), the patient complained of abdominal pain.It was reported that the acidosis level was increased.Ct imaging showed an occlusion of the gore® viabahn® endoprosthesis in the celiac artery.Thrombus aspiration and ballooning were performed to treat the occlusion.Urokinase was then administrated, and the abdominal pain was resolved.Heparin and dual antiplatelet therapy (dapt) were also administrated.The acidosis level returned to a normal level.The patient tolerated the procedure.
 
Manufacturer Narrative
Corrected data: b5 describe event or problem.
 
Event Description
The following was reported to gore; on (b)(6), 2019, the patient underwent endovascular repair.The gore® viabahn® endoprosthesis was implanted in the celiac artery as a chimney device.The procedure was completed without any complications.The same day (6 hours later), the patient complained of abdominal pain.It was reported that the acidosis level was increased.Ct imaging showed an occlusion of the gore® viabahn® endoprosthesis and slightly compressed in the celiac artery.Thrombus aspiration and ballooning were performed to treat the occlusion.Urokinase was then administrated, and the abdominal pain was resolved.Heparin and dual antiplatelet therapy (dapt) were also administrated.The acidosis level returned to a normal level.The patient tolerated the procedure.
 
Manufacturer Narrative
Corrected data: h6 patient code 1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8932948
MDR Text Key156300971
Report Number2017233-2019-00726
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 09/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/18/2019
Device Catalogue NumberJHJR071502J
Device Lot Number16006074
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/26/2019
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received08/28/2019
09/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age63 YR
-
-